Delivery Order SPE2DB22D2006-SPE2DB24FV7KB
Award Date 1/12/24
Potential Completion Date 1/16/24
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,464.31 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies. This competitively awarded, firm fixed-price contract was issued on June 4, 2025, with an ultimate completion date of June 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. No set-aside designation was applied to this award, indicating open competition among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies, valued at $1,063.62 with a firm fixed price structure. The award was issued on December 16, 2025, with an ultimate completion date of December 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside contract represents a competitively awarded delivery order under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,406.09 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector units. The contract was competitively awarded without a set-aside designation and employs firm fixed-price terms with an ultimate completion date of December 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,894.19 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Xyosted 50 mg/0.5 ml auto-injector vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is expected to be fulfilled by January 7, 2026. AmerisourceBergen Drug Corp operates as the subsidiary of...
- The Defense Logistics Agency awarded a delivery order valued at $3,356.53 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 ml auto-injector supplies. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by October 27, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,311.45 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies. The contract is non-competitive with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $4,539.12 to Amerisourcebergen Drug Corporation for the supply of 75 mg/0.5 ml auto-injectors of XYOSTED. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning August 21-22, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set aside designations were indicated. This order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.12 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 ml auto-injector supplies. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order has an ultimate completion date of January 20, 2026, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency has awarded a delivery order valued at $1,067.72 to AmerisourceBergen Drug Corp for XYOSTED 100 MG/0.5 ML auto-injector pharmaceutical supplies. The contract is a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,549.18 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector units on December 1, 2025, with completion scheduled for December 2, 2025. This competitively awarded, firm fixed-price delivery order was placed under a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor and performed the work at its corporate office location in...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV7KBDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 100 mg/0.5 mL XYOSTED auto-injectors. The $1,309.95 order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of January 16, 2024. This delivery order was placed under an existing indefinite delivery contract between AmerisourceBergen Drug Corp and DLA to supply pharmaceuticals and medical supplies in support of military treatment programs and facilities. No set-aside designation was used for this award.
Generated 4/12/24, 9:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/12/24 |